Biotinylated Human EpCAM / TROP1 Protein, Fc,Avitag™

Proteins and Peptides

貨號 Cat. No.
EPM-H82F9
規格 Size
200ug
品牌 Brand
ACROBiosystems
Species
Human
Conjugate
Precision Avi
Expression System
HEK293
Tag
Avi Tag 、 Fc Tag

Description




Source : 


Biotinylated Human EpCAM, Fc,Avitag (EPM-H82F9) is expressed from human 293 cells (HEK293). It contains AA Gln 24 - Lys 265 (Accession # AAH14785.1).


 

Molecule : EpCAM


 

Synonyms : EPCAM,TACSTD1,TROP1,CD326,DIAR5,EGP2,EGP314,EGP40,ESA,GA733-2,HNPCC8,HNPCC-8,KS1/4,KSA,M4S1,MIC18,MK1


 

Format : Powder


 

Category : MABSol® Biotin Labeled Proteins


 

Accession : AAH14785.1


 

Storage : -20℃


 

Shipping condition : Powder,RT


 

Molecular Weight : 56.2 kDa


 

Characteristics :


This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag (Avitag™). The protein has a calculated MW of 56.2 kDa. The protein migrates as 60-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.


 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.


 

Buffer : Tris with Glycine, Arginine and NaCl, pH7.5


 

Description :


EpCAM is also known as CO171A, EGP, EGP40,GA7332, KSA, M4S, MIC18, MK1, TROP1, hEGP2, and is a pan-epithelial differentiation antigen that is expressed on almost all carcinomas as 17-1A(mAb) antigen. Its constitutional function is being elucidated. It is intricately linked with the Cadherin-Catenin pathway and hence the fundamental WNT pathway responsible for intracellular signaling and polarity. The epithelial cell adhesion molecule (Ep-CAM) is known to express in most epithelial malignancies and was reported as a tumor marker or a candidate of molecular targeting therapy.
Ep-CAM cross signaling with N-cadherin involves Pi3K, resulting in the abrogation of the cadherin adhesion complexes in epithelial cells was reported. And Epithelial cell adhesion molecule (Ep-CAM) recently received increased attention as a prognostic factor in breast cancer.


 

References :


(1) Linnenbach, et al., 1993, Mol Cell Biol 13 (3): 1507–15.
(2) Akita H, et al., 2011, Oncogene.
(3) Winter MJ, et al., 2007, Mol Cell Biochem. 302(1-2):19-26.
(4) Schmidt M, et al., 2011, Breast Cancer Res Treat. 125(3):637-46.





詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢